Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2025-12-26 @ 2:42 AM
NCT ID:
NCT03861702
Group ID:
EG000
Title:
FOLFOX + Irinotecan
Description:
Oxaliplatin 60 mg/m2 Intravenously (IV) over 2 hours
Liposomal Irinotecan (free base) 50 mg/m2 IV over 90 minutes after completion of oxaliplatin
Leucovorin 400 mg/m2 IV over 30 minutes after completion of liposomal irinotecan
5-Fluorouracil 2,400 mg/m2 IV over 46 hours via infusion pump at home
All drugs administered on day 1 of each 14 day cycle.
FOLFOX regimen: FOLFOX (Oxaliplatin, Leucovorin, 5-Fluorouracil)
Liposomal Irinotecan: Liposomal Irinotecan
Deaths Number Affected:
13
Deaths Number At Risk:
None
Serious Number Affected:
15
Serious Number At Risk:
28
Other Number Affected:
28
Other Number At Risk:
28
Study:
NCT03861702
Results Section:
NCT03861702
Adverse Events Module:
NCT03861702